- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03869489
Decision Making in Video Games
August 30, 2019 updated by: Tufts University
The purpose of this study is to determine whether anodal transcranial direct current stimulation (tDCS) applied to the left dorsolateral prefrontal cortex induces approach motivation, and whether anodal tDCS applied to the right dorsolateral prefrontal cortex induces avoidance motivation.
This study consists of three experiments: one in which an approach/avoidance video game is validated, one in which the effect of anger and fear on approach/avoidance is studied, and one in which the effect of tDCS is studied.
Only the experiment in which the effect of tDCS is studied involves tDCS.
Study Overview
Status
Withdrawn
Conditions
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Medford, Massachusetts, United States, 02155
- Center for Applied Brain and Cognitive Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal hearing and vision
Exclusion Criteria:
- Left-handedness
- History of seizure, head injury (including neurosurgery), brain injury, diagnosis or a neurological or psychiatric disorder, metal in the head, sensitive scalp
- History of anxiolytic and/or antidepressant medications
- Participation in Experiment #1 or Experiment #2 of the larger study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Anodal left dorsolateral prefrontal cortex tDCS stimulation
|
Anodal tDCS will be applied to the left dorsolateral prefrontal cortex of participants
|
Experimental: Anodal right dorsolateral prefrontal cortex tDCS stimulation
|
Anodal tDCS will be applied to the right dorsolateral prefrontal cortex of participants
|
Sham Comparator: Sham tDCS stimulation
|
Sham tDCS stimulation will be applied
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Avoidance-Approach time difference
Time Frame: 1 year
|
Median of the difference between time to approach and time to avoid a stimulus
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2019
Primary Completion (Anticipated)
April 1, 2020
Study Completion (Anticipated)
April 1, 2020
Study Registration Dates
First Submitted
March 8, 2019
First Submitted That Met QC Criteria
March 8, 2019
First Posted (Actual)
March 11, 2019
Study Record Updates
Last Update Posted (Actual)
September 4, 2019
Last Update Submitted That Met QC Criteria
August 30, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 1809016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
N/A. Study withdrawn
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Change
-
University Ramon LlullAinhoa Nieto Guisado; Mònica Solana-TramuntUnknownCognitive Change | Proprioception Change | Balance ChangeSpain
-
Applied Science & Performance InstituteRecruitingCognitive Change | Mood Change | Mental ProcessesUnited States
-
National Council of Scientific and Technical Research...CompletedSleep | Cognitive Change | Mood Change | CreativityArgentina
-
Wake Forest UniversityNot yet recruiting
-
Biruni UniversityCompletedCognitive ChangeTurkey
-
University of MemphisCalerie LLCCompletedCognitive ChangeUnited States
-
Oregon Health and Science UniversityCompleted
-
University of MiamiUnited States Department of DefenseCompleted
-
Northumbria UniversityPerfetti van Melle SPACompletedCognitive ChangeUnited Kingdom
-
Universidad de GranadaCompleted
Clinical Trials on Anodal left dorsolateral prefrontal cortex tDCS stimulation
-
Stanford UniversityRecruitingDepressive Disorder, Major | Borderline Personality DisorderUnited States
-
Bradley HospitalRecruiting
-
National Institute of Neurological Disorders and...Completed
-
Aalborg UniversityDanish National Research FoundationCompletedAcute Pain | Neuroplasticity | Brain Modulation | Somatosensory FunctionDenmark
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol DependanceUnited States
-
Stanford UniversityCompletedDepression and SuicideUnited States
-
Shanghai Mental Health CenterXuhui Mental Health CenterRecruitingSchizophrenia | Cognitive Impairment | Repetitive Transcranial Magnetic Stimulation | Negative Symptoms in Schizophrenia | Dorsolateral Prefrontal CortexChina
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine Withdrawal | Tobacco AbstinenceUnited States
-
United States Naval Medical Center, San DiegoCompletedPTSD, Post Traumatic Stress DisorderUnited States
-
Washington University School of MedicineCompleted